EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EDAP TMS SA (EDAP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7515
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EDAP TMS SA (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. It offers High Intensity Focused Ultrasound (HIFU) devices for the treatment of localized prostate cancer; and extracorporeal shock-wave lithotripters (ESWL) for the treatment of urinary tract stones. The company offers its products to hospitals, urology clinics and research institutions. The company also offers HIFU mobile treatment services, which provides access to its HIFU devices without requiring hospitals and clinics to make an up-front investment in the equipment. EDAP markets its products through direct sales force, representative offices, subsidiaries and distributors in the Americas, Europe, the Middle East, Africa and Asia-Pacific. EDAP is headquartered in Vaulx-en-Velin, France.

EDAP TMS SA (EDAP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EDAP TMS SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EDAP TMS SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EDAP TMS SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EDAP TMS SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EDAP TMS SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EDAP TMS SA, Medical Equipment, Deal Details 10
Partnerships 10
Theraclion Enters into Distribution Agreement with EDAP TMS 10
EDAP TMS Enters into Agreement with Laborie Medical 11
Equity Offering 12
Edap Tms Raises USD11.5 Million in Private Placement of ADS 12
EDAP TMS Raises USD9.3 Million in Private Placement of American Depositary Shares 14
EDAP TMS Announces Private Placement Of American Depositary Shares For US$12 Million 16
EDAP TMS Announces Private Placement Of Shares For US$5.625 Million 17
EDAP TMS SA – Key Competitors 18
EDAP TMS SA – Key Employees 19
EDAP TMS SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 29, 2018: EDAP announces 2018 Second Quarter Results 21
Aug 29, 2018: EDAP TMS announces 2018 second quarter financial results 23
May 14, 2018: EDAP Reports 2018 First Quarter Results 25
Mar 27, 2018: EDAP TMS Reports 2017 Annual Results 26
Nov 15, 2017: EDAP TMS Reports Third Quarter 2017 Results 28
Aug 23, 2017: EDAP TMS Reports Record Second Quarter and First Half 2017 Results 30
May 17, 2017: EDAP TMS SA Reports First Quarter 2017 Results 32
Apr 03, 2017: EDAP Achieves 63% Growth in HIFU Revenue in 2016 33
Feb 23, 2017: EDAP Announces Preliminary Unaudited Full Year 2016 Revenue 35
Corporate Communications 36
Mar 06, 2017: EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the US 36
Other Significant Developments 37
Dec 18, 2017: EDAP’s Focal One Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey 37
Aug 31, 2017: EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU 38
Mar 08, 2017: EDAP’s Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation 39
Jan 23, 2017: EDAP to Exclusively Distribute LABORIE’s Medical Measurement Systems 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
EDAP TMS SA, Medical Equipment, Key Facts, 2017 2
EDAP TMS SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EDAP TMS SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EDAP TMS SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EDAP TMS SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EDAP TMS SA, Deals By Market, 2012 to YTD 2018 8
EDAP TMS SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Theraclion Enters into Distribution Agreement with EDAP TMS 10
EDAP TMS Enters into Agreement with Laborie Medical 11
Edap Tms Raises USD11.5 Million in Private Placement of ADS 12
EDAP TMS Raises USD9.3 Million in Private Placement of American Depositary Shares 14
EDAP TMS Announces Private Placement Of American Depositary Shares For US$12 Million 16
EDAP TMS Announces Private Placement Of Shares For US$5.625 Million 17
EDAP TMS SA, Key Competitors 18
EDAP TMS SA, Key Employees 19
EDAP TMS SA, Subsidiaries 20

List of Figures
EDAP TMS SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EDAP TMS SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EDAP TMS SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EDAP TMS SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EDAP TMS SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EDAP TMS SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EDAP TMS SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EDAP TMS SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elektro Eletricidade E Servicos SA (EKTR3):電力:M&Aディール及び事業提携情報
    Summary Elektro Eletricidade E Servicos SA (Elektro Eletricidade) is an electric energy distributor that offers power supply and utility services. The company provides electric services to home, business and public environments. It offers services such as electricity bill, debits, change due, accoun …
  • Seacoast Banking Corporation of Florida:企業の戦略・SWOT・財務情報
    Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report Summary Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Idorsia Pharmaceutical Ltd (IDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idorsia Pharmaceutical Ltd (Idorsia) is a manufacturer and developer of medicine that discovers, develops various therapies. The company provides pipeline portfolio such as investigational candidates targeted at the treatment of resistant hypertension, chronic insomnia, vasospasm, and system …
  • Citigroup Inc:企業のM&A・事業提携・投資動向
    Citigroup Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Citigroup Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • MBDA Holdings SAS:企業の戦略・SWOT・財務情報
    MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report Summary MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BHG SA – Brazil Hospitality Group:企業の戦略・SWOT・財務分析
    BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report Summary BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Enercon Services Inc:電力:M&Aディール及び事業提携情報
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務分析
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OncoMed Pharmaceuticals Inc (OMED):企業の財務・戦略的SWOT分析
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • WellCare Health Plans Inc (WCG):製薬・医療:M&Aディール及び事業提携情報
    Summary WellCare Health Plans Inc (WellCare) is a managed care services provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordina …
  • Lees Foods Ltd.:企業の戦略・SWOT・財務分析
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bastide Le Confort Medical SA (BLC)-医療機器分野:企業M&A・提携分析
    Summary Bastide Le Confort Medical SA (Bastide Le) is a medical equipment company that provides personal care products. The company offers medical devices for individuals and home health care professionals. It provides products such as lift chairs and accessories, pillows, cushions and special seati …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務分析
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ClearStream Energy Services Inc:企業の戦略・SWOT・財務情報
    ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report Summary ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • OncBioMune Pharmaceuticals Inc (OBMP):企業の財務・戦略的SWOT分析
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆